Share on Facebook
Share on Twitter
Share on LinkedIn

A federal court in Virginia on Tuesday approved a settlement in which Abbott Laboratories agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.

Abbott agreed in May to pay a criminal fine and forfeiture of $700 million and settlements with the federal government and states totaling $800 million. The settlement was approved Tuesday in U.S. District Court in Abingdon. Virginia will receive $4.2 million from the civil settlement.

Click here to read more.